Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00275457
Recruitment Status : Completed
First Posted : January 12, 2006
Last Update Posted : October 31, 2013
Information provided by:
Boehringer Ingelheim

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2004
  Estimated Study Completion Date : April 2004